One day busulfan (Bu) and high dose of cyclophosphamide (Cy) as preparative regimen for bone marrow transplantation (BMT) in patients with severe aplastic anemia (SAA).

被引：0
|
作者：
Pallotta, RS [1 ]
Macedo, MCMA [1 ]
Saboya, R [1 ]
Dzik, C [1 ]
Silva, RL [1 ]
Loterio, H [1 ]
Massumoto, CM [1 ]
Chamone, DAF [1 ]
Dulley, FL [1 ]
机构：
[1] UNIV SAO PAULO,SCH MED,DISCIPLINE HEMATOL,FDN SANGUE HEMOCTR,BMT PROGRAM,SAO PAULO,BRAZIL
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4507 / 4507
页数：1
相关论文
共 50 条
  • [31] BONE-MARROW TRANSPLANTATION (BMT) IN SEVERE APLASTIC-ANEMIA (SAA) - RESULTS OBTAINED IN 20 CONSECUTIVE PATIENTS
    SCHMIDMEIER, W
    HINTERBERGER, W
    HOCKER, P
    HAJEKROSENMAYR, A
    FISCHER, M
    GEISSLER, K
    KARCHER, KH
    ALTH, G
    VOLCPLATZER, B
    GRABNER, G
    LECHNER, K
    GADNER, H
    DEUTSCH, E
    BLUT, 1985, 51 (03): : 236 - 236
  • [32] Bone marrow transplantation (BMT) or immunosuppressive therapy (IS) for patients with severe aplastic anemia (SAA): A report of the European group for blood and marrow transplantation (EBMT).
    Bacigalupo, A
    Brand, R
    Socie, G
    Passweg, J
    Locasciulli, A
    Van Lint, MT
    Tichelli, A
    McCann, S
    Marsh, J
    Ljungman, P
    Hows, J
    Marin, P
    Schrezenmeier, H
    BLOOD, 1998, 92 (10) : 158A - 158A
  • [33] Toxicity and outcome of busulfan and cyclophosphamide preparative regimen in bone marrow transplantation.
    Reddy, VS
    Rao, R
    Lipton, J
    Hao, Y
    Fyles, G
    Tejpar, I
    Minden, MD
    Atkins, H
    Meharchand, J
    Messner, HA
    BLOOD, 1995, 86 (10) : 3834 - 3834
  • [34] BUSULFAN AND CYCLOPHOSPHAMIDE AS A PREPARATIVE REGIMEN FOR BONE-MARROW TRANSPLANTATION IN PATIENTS WITH PRIOR CHEST RADIOTHERAPY
    VANDERJAGT, RHC
    APPELBAUM, FR
    PETERSEN, FB
    BIGELOW, CL
    FISHER, LD
    SCHOCH, GH
    BUCKNER, CD
    SANDERS, JE
    STORB, R
    SULLIVAN, KM
    THOMAS, ED
    BONE MARROW TRANSPLANTATION, 1991, 8 (03) : 211 - 215
  • [35] Bone Marrow Transplantation (BMT) for patients (pts) with aplastic anemia -: effectiveness of Cyclophosphamide (CY) and ATG regimen versus CY alone in the prevention of graft failure:: single-center experience
    Martins, C
    Lacerda, JF
    Carmo, JA
    Lourenço, F
    Juncal, C
    Lacerda, JMF
    BONE MARROW TRANSPLANTATION, 2001, 27 : S114 - S114
  • [36] ALLOGENEIC BONE MARROW TRANSPLANTATION WITH CYCLOPHOSPHAMIDE AND LOW DOSE ALEMTUZUMAB FOR SEVERE APLASTIC ANEMIA
    Bittencourt, H.
    Lodi, F.
    Fischer, G.
    Fogliatto, L.
    Lamego, R.
    Veloso, G.
    Vieira, A. K.
    Magalhaes, G.
    Magalhaes, S.
    Coutinho, M. C.
    Licinio, R.
    Capra, M.
    Borges, L.
    Tiburcio, A. F.
    Macedo, A. V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 328 - 328
  • [37] High dose cyclophosphamide (CY) for severe aplastic anemia (SAA): Safety and long term follow-up.
    Brodsky, RA
    Chen, A
    Dorr, DM
    Brodsky, I
    Jones, RJ
    BLOOD, 2005, 106 (11) : 41A - 42A
  • [38] PULMONARY COMPLICATIONS OF BONE-MARROW TRANSPLANTATION (BMT) - A COMPARISON OF TOTAL-BODY IRRADIATION AND CYCLOPHOSPHAMIDE (TBI-CY) TO BUSULFAN AND CYCLOPHOSPHAMIDE (BU-CY)
    HARTSELL, WF
    GHALIE, R
    RUBIN, D
    KAIZER, H
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 : 186 - 186
  • [39] Busulfan, cyclophosphamide, etoposide and granulocyte-colony stimulating factor (BU/CY/ETP/G-CSF) combination as a preparative regimen for bone marrow transplantation (BMT) in high-risk leukemia patients: A phase 1 study
    Kanda, Y
    Akiyama, H
    Tanikawa, S
    Sakamaki, H
    Sasaki, T
    Takamoto, S
    Onozawa, Y
    BLOOD, 1995, 86 (10) : 3792 - 3792
  • [40] BONE-MARROW TRANSPLANTATION (BMT) FOR SEVERE APLASTIC-ANEMIA (SAA) IN EUROPE - A REPORT OF THE EBMT-SAA WORKING PARTY
    BACIGALUPO, A
    VANLINT, MT
    CONGIU, M
    MARMONT, AM
    BONE MARROW TRANSPLANTATION, 1988, 3 : 44 - 45
12345